129 related articles for article (PubMed ID: 7863250)
1. Acid inhibitory characteristics of nizatidine in man: an overview.
Parente F; Bianchi Porro G
Scand J Gastroenterol Suppl; 1994; 206():3-7. PubMed ID: 7863250
[TBL] [Abstract][Full Text] [Related]
2. Early evening nizatidine intake with a meal optimizes the antisecretory effect.
Duroux P; Emde C; Bauerfeind P; Biollaz J; Armstrong D; Blum AL
Aliment Pharmacol Ther; 1993 Feb; 7(1):47-54. PubMed ID: 8439637
[TBL] [Abstract][Full Text] [Related]
3. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
4. Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
Thompson A; Kirdeikis P; Jamali F; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
J Gastroenterol Hepatol; 1995; 10(5):546-54. PubMed ID: 8963030
[TBL] [Abstract][Full Text] [Related]
5. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
6. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
7. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
8. The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion.
Wajima Z; Shitara T; Inoue T; Yoshikawa T; Ogawa R
Anaesth Intensive Care; 2000 Feb; 28(1):46-8. PubMed ID: 10701036
[TBL] [Abstract][Full Text] [Related]
9. The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
Kovacs TO; Van Deventer GM; Maxwell V; Sytnik B; Walsh JH
Scand J Gastroenterol Suppl; 1987; 136():41-6. PubMed ID: 2892254
[TBL] [Abstract][Full Text] [Related]
10. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
11. Nizatidine and cisapride increase salivary secretion in rats.
Adachi K; Furuta K; Katsube T; Fujisawa T; Azumi T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
Dig Dis Sci; 2004 Mar; 49(3):399-403. PubMed ID: 15139487
[TBL] [Abstract][Full Text] [Related]
12. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.
Fullarton GM; McLauchlan G; Macdonald A; Crean GP; McColl KE
Gut; 1989 Apr; 30(4):449-54. PubMed ID: 2565860
[TBL] [Abstract][Full Text] [Related]
13. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
14. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
16. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Lin TM; Evans DC; Warrick MW; Pioch RP
J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of oral nizatidine.
Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
[TBL] [Abstract][Full Text] [Related]
18. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
Neubauer BL; Goode RL; Best KL; Hirsch KS; Lin TM; Pioch RP; Probst KS; Tinsley FC; Shaar CJ
Toxicol Appl Pharmacol; 1990 Feb; 102(2):219-32. PubMed ID: 1967857
[TBL] [Abstract][Full Text] [Related]
19. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
20. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man.
Boyd EJ; Wormsley KG
Eur J Clin Pharmacol; 1984; 26(4):443-7. PubMed ID: 6145595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
